연구성과로 돌아가기
2023 연구자 정보 (146 / 1135)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Tseng, Kuo-Chih (Tseng, KC) |
Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Chiayi, Taiwan Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Internal Med, Chiayi, Taiwan |
|
|
[JCR상위 4.5] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Uchida, Yasushi (Uchida, Y) |
Matsue Red Cross Hosp, Dept Gastroenterol, Matsue, Shimane, Japan |
|
|
[JCR상위 4.5] Outcome of untreated low-level viremia versus antiviral therapy-induced or spontaneous undetectable HBV-DNA in compensated cirrhosis | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | daniel_huang@nus.edu.sg;nobuharu.tamaki@gmail.com;psyoung0419@gmail.com;kurosaki@musashino.jrc.or.jp;h.marusawa@osaka-med.jrc.or.jp;matoshi@matsuyama.jrc.or.jp;Masachan44@gmail.com;laboratory@matsue.jrc.or.jp;kobashi0584@gmail.com;furuta-k@masuda.jrc.or.jp;izumi012@musashino.jrc.or.jp;beomkkim@yuhs.ac;sinndhn@hanmail.net; | ||
|
Um, Soonho (Um, S) |
Korea Univ, Coll Med, Seoul, South Korea |
|
|
[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Vardeu, Antonella (Vardeu, A) |
Vaccitech, Res, Oxford, England |
|
|
[JCR상위 4.5] PHASE 1b/2a STUDY OF HETEROLOGOUS ChAdOx1-HBV/MVA-HBV THERAPEUTIC VACCINATION (VTP-300) COMBINED WITH LOW-DOSE NIVOLUMAB (LDN) IN VIRALLY-SUPPRESSED PATIENTS WITH CHB ON NUCLEOS(T)IDE ANALOGUES | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Wang, Feng (Wang, F) |
Chungbuk Natl Univ, Cheongju, South Korea |
|
|
[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Wang, Hongyuan (Wang, HY) |
Gilead Sci Inc, Foster City, CA USA |
JWP-2279-2024 wang, hongyuan |
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Wang, Jiguang (Wang, JG) |
교신저자 |
Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Clear Water Bay, Hong Kong, Peoples R China Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China InnoHK, Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China HKUST Shenzhen Hong Kong Collaborat Innovat Res In, Shenzhen, Peoples R China |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | |
|
Woo, Hyun Young (Woo, HY) |
제1저자 |
Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea Pusan Natl Univ Hosp, Busan, South Korea Pusan Natl Univ, Busan, South Korea |
|
|
[JCR상위 4.5] REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA [JCR상위 1.7] Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma [JCR상위 4.5] AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆ [JCR상위 4.5] HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | jheo@pusan.ac.kr; | |
|
Wu, Jia-Feng (Wu, JF) |
Natl Taiwan Univ Hosp, Taipei, Taiwan |
KZU-6709-2024 Wu, Jiafeng |
|
[JCR상위 4.5] EFFICACY AND SAFETY OF TENOFOVIR ALAFENAMIDE ( TAF) AT 2 YEARS IN CHILDREN AND ADOLESCENTS WITH CHRONIC HEPATITIS B ( CHB) | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Yang, Jin Mo (Yang, JM) |
Catholic Univ Korea, Seoul, South Korea |
|
|
[JCR상위 4.5] DECREASED RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS B TREATED WITH BESIFOVIR | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Yang, Yingxi (Yang, YX) |
Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China |
|
|
[JCR상위 4.5] Pharmacogenomic profiling reveals molecular features of chemotherapy resistance in IDH wild-type primary glioblastoma | SCIE | 4.5 | GENETICS & HEREDITY | nsproper@naver.com;benedict.yoon@samsung.com;jgwang@ust.hk; | ||
|
Yang, Yoon Mee (Yang, YM) |
Kangwon Natl Univ, Chunchon, South Korea |
NQF-2987-2025 Yang, YoonMee |
|
[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Yi, Ki Youn (Yi, KY) |
Pusan Natl Univ, Coll Med, Dept Internal Med, Busan, South Korea Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea |
|
|
[JCR상위 4.5] REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Yoo, Hwan-Soo (Yoo, HS) |
Chungbuk Natl Univ, Cheongju, South Korea |
N-4449-2018 Yoo, Hwan |
|
[JCR상위 4.5] ALPHA-1 ANTITRYPSIN/ PROTEINASE 3 IMBALANCE EXERTS PROTEOLYTIC REGULATION ON INTERLEUKIN-32 GAMMA TO PROMOTE NONALCOHOLIC STEATOHEPATITIS | SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | |||
|
Yoon, Jung-Hwan (Yoon, JH) |
Seoul Natl Univ, Coll Med, Seoul, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea Seoul Natl Univ, Liver Res Inst, Coll Med, Seoul, South Korea |
J-5563-2012 Yoon, Jung |
|
[JCR상위 4.5] PROTON PUMP INHIBITOR TREATMENT IS ASSOCIATED WITH A HIGHER MORTALITY IN CIRRHOTIC PATIENTS: A MULTICENTER STUDY [JCR상위 8.7] Personalized Antiviral Drug Selection in Patients With Chronic Hepatitis B Using a Machine Learning Model: A Multinational Study |
SCIE | 4.5 | GASTROENTEROLOGY & HEPATOLOGY | mhhur@snu.ac.kr;alsrud627@snu.ac.kr;terryfungyip@gmail.com;e580306@ms31.hinet.net;vital@snu.ac.kr;dr.choi85@gmail.com;KSUKOREA@yuhs.ac;limys@amc.seoul.kr;psyoung0419@gmail.com;wonglaihung@mect.cuhk.edu.hk;sinndhn@gmail.com;jyj412@hanmail.net;sekim@hallym.or.kr;cypeng@mail.cmuh.org.tw;drshp@khu.ac.kr;5137ccy@gmail.com;hwiyoung@gmail.com;amelia86@naver.com;gandorie@gmail.com;noshin@hanyang.ac.kr;mseileen80@hanyang.ac.kr;sonjh@hanyang.ac.kr;dr486@eulji.ac.kr;jshim3927@gmail.com;jeongsw@schmc.ac.kr;choyk2004.cho@samsung.com;hskim@kdh.or.kr;mjjang2014@naver.com;yoonjun@snu.ac.kr;yoonjh@snu.ac.kr;pindra@empal.com; |
페이지 이동: